Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
INTS
INTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INTS News
Intensity Therapeutics Reports FY Losses
Mar 27 2026
seekingalpha
Intensity Therapeutics Reports 2025 Year-End Financial Results and Corporate Update
Mar 27 2026
PRnewswire
Intensity Therapeutics Reports 2025 Financial Results and Study Updates
Mar 27 2026
Newsfilter
Intensity Therapeutics Inc. Expands ATM Facility to Improve Financial Flexibility, According to SEC Filing
Mar 23 2026
moomoo
Intensity Therapeutics Inc. Plans to Offer Up to $60 Million in Common Stock, According to SEC Filing
Mar 23 2026
moomoo
Intensity Therapeutics Updates on INVINCIBLE-4 Study Progress
Mar 12 2026
Benzinga
Intensity Therapeutics Updates on INVINCIBLE-4 Study Progress
Mar 12 2026
PRnewswire
Preliminary Results of INT230-6 Study Show Promising Efficacy
Mar 12 2026
Newsfilter
Intensity Therapeutics Regains Nasdaq Compliance
Mar 06 2026
seekingalpha
Intensity Therapeutics Regains Nasdaq Compliance
Mar 06 2026
PRnewswire
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 13 2026
Benzinga
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 13 2026
stocktwits
Intensity Therapeutics Announces Reverse Stock Split Plan
Feb 13 2026
PRnewswire
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 13 2026
Newsfilter
Intensity Therapeutics Inc. Board Greenlights 1-for-25 Reverse Stock Split
Feb 13 2026
moomoo
Intensity Therapeutics Highlights 2025 Milestones and 2026 Strategic Priorities
Jan 13 2026
PRnewswire
Show More News
